http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0324014-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56ee5285e8e8edccb061046ff20da7a6
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
filingDate 1990-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_999ba431e5599c8009aa1bc498df9744
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f29681203721ab801ac15f476db1202
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff4f05339b57a206f1297dc6ed0f8b3c
publicationDate 1991-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0324014-A
titleOfInvention Use of naetopidil for treating dysuria in benign prostate hypertrophy
abstract PURPOSE: To prepare a therapeutic agent for dysuria in benign prostate hypertrophy comprising naftopidil or its salt as an active ingredient. n CONSTITUTION: This therapeutic agent for dysuria comprises 1-(2- methoxyphenyl)-4-[3-(naphth-l-yl-oxy)-2-hydroxy-propyll-piperazine (naftopidil), having antihypertensive action, known to control anaphylactic reaction caused by dextran in a rat and represented by the formula as an active ingredient. The compound is especially orally applied and the daily dose thereof is 10-100mg and administered in a dose of 10-50mg at a time daily once or twice. n COPYRIGHT: (C)1991,JPO
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104321313-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6861070-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013102249-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02062390-A1
priorityDate 1989-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499359
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4418
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226485917

Total number of triples: 25.